Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes.

Lev A, Simon AJ, Trakhtenbrot L, Goldstein I, Nagar M, Stepensky P, Rechavi G, Amariglio N, Somech R.

Clin Dev Immunol. 2012;2012:261470. doi: 10.1155/2012/261470.

2.

Thymic function in MHC class II-deficient patients.

Lev A, Simon AJ, Broides A, Levi J, Garty BZ, Rosenthal E, Amariglio N, Rechavi G, Somech R.

J Allergy Clin Immunol. 2013 Mar;131(3):831-9. doi: 10.1016/j.jaci.2012.10.040.

PMID:
23228244
3.

Defining combined immunodeficiency.

Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, Grunebaum E.

J Allergy Clin Immunol. 2012 Jul;130(1):177-83. doi: 10.1016/j.jaci.2012.04.029.

PMID:
22664165
4.

Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.

Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R, Chen DF, Reinsmoen NL, Buckley RH.

J Allergy Clin Immunol. 2007 Aug;120(2):423-8.

PMID:
17481714
5.

T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.

Sarzotti M, Patel DD, Li X, Ozaki DA, Cao S, Langdon S, Parrott RE, Coyne K, Buckley RH.

J Immunol. 2003 Mar 1;170(5):2711-8.

6.

Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells.

Somech R, Simon AJ, Lev A, Dalal I, Spirer Z, Goldstein I, Nagar M, Amariglio N, Rechavi G, Roifman CM.

J Allergy Clin Immunol. 2009 Oct;124(4):793-800. doi: 10.1016/j.jaci.2009.06.048.

PMID:
19767069
7.

Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.

Somech R, Lev A, Simon AJ, Korn D, Garty BZ, Amariglio N, Rechavi G, Almashanu S, Zlotogora J, Etzioni A.

Isr Med Assoc J. 2013 Aug;15(8):404-9.

9.

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG.

J Exp Med. 1994 Feb 1;179(2):493-502.

10.
11.
12.

Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency.

Knobloch C, Goldmann SF, Friedrich W.

J Immunol. 1991 Jun 15;146(12):4157-64.

PMID:
1710242
13.

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.

Hum Immunol. 2004 Feb;65(2):142-56.

PMID:
14969769
14.

IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells.

Heninger AK, Theil A, Wilhelm C, Petzold C, Huebel N, Kretschmer K, Bonifacio E, Monti P.

J Immunol. 2012 Dec 15;189(12):5649-58. doi: 10.4049/jimmunol.1201286.

15.

Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients.

Müller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W.

Blood. 2001 Sep 15;98(6):1847-51.

16.
17.

Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.

Vandenbark AA, Culbertson NE, Bartholomew RM, Huan J, Agotsch M, LaTocha D, Yadav V, Mass M, Whitham R, Lovera J, Milano J, Theofan G, Chou YK, Offner H, Bourdette DN.

Immunology. 2008 Jan;123(1):66-78.

18.

Characterization of ζ-associated protein, 70 kd (ZAP70)-deficient human lymphocytes.

Roifman CM, Dadi H, Somech R, Nahum A, Sharfe N.

J Allergy Clin Immunol. 2010 Dec;126(6):1226-33.e1. doi: 10.1016/j.jaci.2010.07.029.

PMID:
20864151
19.

Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals.

Antons AK, Wang R, Kalams SA, Unutmaz D.

PLoS One. 2008 Aug 13;3(8):e2952. doi: 10.1371/journal.pone.0002952.

20.

The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.

Lev A, Simon AJ, Bareket M, Bielorai B, Hutt D, Amariglio N, Rechavi G, Somech R.

PLoS One. 2012;7(1):e30494. doi: 10.1371/journal.pone.0030494.

Items per page

Supplemental Content

Support Center